Monthly Extended-Release Risperidone (RBP-7000) in the Treatment of Schizophrenia
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001076
Abstract: Supplemental digital content is available in the text. Abstract Purpose/Background The Phase 3 program for RBP-7000, a once-monthly subcutaneous (SC) extended-release risperidone formulation approved for treatment of schizophrenia, consisted of a double-blind placebo-controlled trial (previously… read more here.
Keywords: rbp; rbp 7000; treatment; release risperidone ... See more keywords
Evaluating Non-Conventional Chitosan Sources for Controlled Release of Risperidone
Sign Up to like & getrecommendations! Published in 2022 at "Polymers"
DOI: 10.3390/polym14071355
Abstract: In this work, two chitosan samples from cuttlebone and squid pen are produced and characterized. We studied the formation of thermoresponsive hydrogels with β-glycerol phosphate and found proper formulations that form the hydrogels at 37… read more here.
Keywords: release risperidone; chitosan; chitosan sources; controlled release ... See more keywords